Browse

Treatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: radiotherapy versus chemoradiotherapy

DC Field Value Language
dc.contributor.authorKim, Kyubo-
dc.contributor.authorChie, Eui Kyu-
dc.contributor.authorKim, Chul Woo-
dc.contributor.authorKim, Il Han-
dc.contributor.authorPark, Charn Il-
dc.date.accessioned2009-10-01T05:08:16Z-
dc.date.available2009-10-01T05:08:16Z-
dc.date.issued2005-02-01-
dc.identifier.citationJpn J Clin Oncol 2005;35(1):1-5.en
dc.identifier.issn0368-2811 (Print)-
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15681596-
dc.identifier.urihttps://hdl.handle.net/10371/10016-
dc.description.abstractOBJECTIVE: The purpose of this study was to evaluate the treatment outcome of angiocentric T-cell and natural killer (NK)/T-cell lymphoma, nasal type. METHODS: Between February 1989 and March 2001, 53 patients with newly diagnosed angiocentric T-cell and NK/T-cell lymphoma, nasal type involving the head and neck, were treated with radiation therapy (RT). There were 37 males and 16 females. The median age of the patients was 45 years (range 19-73). Twenty of them were treated with chemoradiotherapy (CRT), while 33 with treated with RT alone. The median follow-up period was 74 months (range 6-173). RESULTS: The 5-year overall survival rate of all patients was 69%. CRT appeared to be inferior to RT alone in terms of 5-year overall survival, though the difference was not statistically significant (59 versus 76%, P = 0.27). CONCLUSIONS: There was no difference in survival between RT and CRT in angiocentric T-cell and NK/T-cell lymphoma, nasal type.en
dc.language.isoenen
dc.publisherOxford University Pressen
dc.subjectAdulten
dc.subjectAgeden
dc.subjectAntineoplastic Combined Chemotherapy Protocols/therapeutic useen
dc.subjectCombined Modality Therapyen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectImmunophenotypingen
dc.subject*Killer Cells, Naturalen
dc.subjectLymphoma, T-Cell/*drug therapy/mortality/*radiotherapyen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectNose Neoplasms/*drug therapy/mortality/*radiotherapyen
dc.subjectRadiotherapy Dosageen
dc.subjectSurvival Rateen
dc.subjectTreatment Outcomeen
dc.titleTreatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: radiotherapy versus chemoradiotherapyen
dc.typeArticleen
dc.contributor.AlternativeAuthor김규보-
dc.contributor.AlternativeAuthor지의규-
dc.contributor.AlternativeAuthor김철우-
dc.contributor.AlternativeAuthor김일한-
dc.contributor.AlternativeAuthor박찬일-
dc.identifier.doi10.1093/jjco/hyi006-
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Pathology (병리학전공)Journal Papers (저널논문_병리학전공)
Files in This Item:
There are no files associated with this item.
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse